DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
PBT-1033 is an investigational drug.
There have been 5 clinical trials for PBT-1033. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2008.
The most common disease conditions in clinical trials are Esophageal Neoplasms, Adenocarcinoma, and Lung Neoplasms. The leading clinical trial sponsors are NRG Oncology, National Cancer Institute (NCI), and Mayo Clinic.
Recent Clinical Trials for PBT-1033
|Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer||National Cancer Institute (NCI)||Phase 3|
|Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer||NRG Oncology||Phase 3|
|Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy||xjpfW||N/A|